Literature DB >> 21541677

Acyl-CoA binding proteins interact with the acyl-CoA binding domain of mitochondrial carnitine palmitoyl transferase I.

Heather A Hostetler1, Dan Lupas, Yingran Tan, Jia Dai, Matthew S Kelzer, Gregory G Martin, Gebre Woldegiorgis, Ann B Kier, Friedhelm Schroeder.   

Abstract

Although the rate limiting step in mitochondrial fatty acid oxidation, catalyzed by carnitine palmitoyl transferase I (CPTI), utilizes long-chain fatty acyl-CoAs (LCFA-CoA) as a substrate, how LCFA-CoA is transferred to CPTI remains elusive. Based on secondary structural predictions and conserved tryptophan residues, the cytoplasmic C-terminal domain was hypothesized to be the LCFA-CoA binding site and important for interaction with cytoplasmic LCFA-CoA binding/transport proteins to provide a potential route for LCFA-CoA transfer. To begin to address this question, the cytoplasmic C-terminal region of liver CPTI (L-CPTI) was recombinantly expressed and purified. Data herein showed for the first time that the L-CPTI C-terminal 89 residues were sufficient for high affinity binding of LCFA-CoA (K (d) = 2-10 nM) and direct interaction with several cytoplasmic LCFA-CoA binding proteins (K (d) < 10 nM), leading to enhanced CPTI activity. Furthermore, alanine substitutions for tryptophan in L-CPTI (W391A and W452A) altered secondary structure, decreased binding affinity for LCFA-CoA, and almost completely abolished L-CPTI activity, suggesting that these amino acids may be important for ligand stabilization necessary for L-CPTI activity. Moreover, while decreased activity of the W452A mutant could be explained by decreased binding of lipid binding proteins, W391 itself seems to be important for activity. These data suggest that both interactions with lipid binding proteins and the peptide itself are important for optimal enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541677      PMCID: PMC3149718          DOI: 10.1007/s11010-011-0847-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  The search for new ways to treat obesity.

Authors:  Jules Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

2.  Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene.

Authors:  Gregory G Martin; Heike Danneberg; Leena S Kumar; Barbara P Atshaves; Erdal Erol; Michael Bader; Friedhelm Schroeder; Bert Binas
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

3.  Identification by mutagenesis of conserved arginine and tryptophan residues in rat liver carnitine palmitoyltransferase I important for catalytic activity.

Authors:  J Dai; H Zhu; J Shi; G Woldegiorgis
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

4.  The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase I.

Authors:  K A Abo-Hashema; M H Cake; M A Lukas; J Knudsen
Journal:  Int J Biochem Cell Biol       Date:  2001-08       Impact factor: 5.085

Review 5.  Gene structure, intracellular localization, and functional roles of sterol carrier protein-2.

Authors:  A M Gallegos; B P Atshaves; S M Storey; O Starodub; A D Petrescu; H Huang; A L McIntosh; G G Martin; H Chao; A B Kier; F Schroeder
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

6.  Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set.

Authors:  N Sreerama; R W Woody
Journal:  Anal Biochem       Date:  2000-12-15       Impact factor: 3.365

7.  Membrane charge and curvature determine interaction with acyl-CoA binding protein (ACBP) and fatty acyl-CoA targeting.

Authors:  Hsu Chao; Gregory G Martin; William K Russell; Suryakant D Waghela; David H Russell; Friedhelm Schroeder; Ann B Kier
Journal:  Biochemistry       Date:  2002-08-20       Impact factor: 3.162

8.  Sterol carrier protein-2/sterol carrier protein-x expression differentially alters fatty acid metabolism in L cell fibroblasts.

Authors:  Barbara P Atshaves; Stephen M Storey; Friedhelm Schroeder
Journal:  J Lipid Res       Date:  2003-06-16       Impact factor: 5.922

9.  Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism.

Authors:  Barbara P Atshaves; Stephen M Storey; Huan Huang; Friedhelm Schroeder
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

Review 10.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.

Authors:  Jean-Paul Bonnefont; Fatima Djouadi; Carina Prip-Buus; Stephanie Gobin; Arnold Munnich; Jean Bastin
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec
View more
  19 in total

1.  The PDZ1 and PDZ3 domains of MAGI-1 regulate the eight-exon isoform of the coxsackievirus and adenovirus receptor.

Authors:  Abimbola Olayinka Kolawole; Priyanka Sharma; Ran Yan; Kyle Joseph Edward Lewis; Zhigang Xu; Heather Ann Hostetler; Katherine Julie Diane Ashbourne Excoffon
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

2.  Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-01-04       Impact factor: 4.698

3.  The PDZ3 domain of the cellular scaffolding protein MAGI-1 interacts with the Coxsackievirus and adenovirus receptor (CAR).

Authors:  Ran Yan; Priyanka Sharma; Abimbola O Kolawole; Sterling C T Martin; James M Readler; Poornima L N Kotha; Heather A Hostetler; Katherine J D A Excoffon
Journal:  Int J Biochem Cell Biol       Date:  2015-01-23       Impact factor: 5.085

4.  High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.

Authors:  Anca D Petrescu; Avery L McIntosh; Stephen M Storey; Huan Huang; Gregory G Martin; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochim Biophys Acta       Date:  2013-06-06

5.  Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Friedhelm Schroeder; Ann B Kier
Journal:  Arch Biochem Biophys       Date:  2015-06-24       Impact factor: 4.013

6.  Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice.

Authors:  Sherrelle Milligan; Gregory G Martin; Danilo Landrock; Avery L McIntosh; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-12-06       Impact factor: 4.698

7.  Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice.

Authors:  Avery L McIntosh; Barbara P Atshaves; Danilo Landrock; Kerstin K Landrock; Gregory G Martin; Stephen M Storey; Ann B Kier; Friedhelm Schroeder
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

8.  The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.

Authors:  Gregory G Martin; Avery L McIntosh; Huan Huang; Shipra Gupta; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  Biochemistry       Date:  2013-12-10       Impact factor: 3.162

9.  4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation.

Authors:  Beom K Choi; Do Y Lee; Don G Lee; Young H Kim; Seon-Hee Kim; Ho S Oh; Chungyong Han; Byoung S Kwon
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

10.  Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.

Authors:  Avery L McIntosh; Huan Huang; Stephen M Storey; Kerstin K Landrock; Danilo Landrock; Anca D Petrescu; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.